Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies

European Journal of Endocrinology

Volumn 162, Issue 2, 2010, Pages 361-369

  Brozzetti, Annalisa ^a   Marzotti, Stefania ^a   Tortoioli, Cristina ^a   Bini, Vittorio ^a   Giordano, Roberta ^b   Dotta, Francesco ^c   Betterle, Corrado ^d   De Bellis, Annamaria ^e   Arnaldi, Giorgio ^f   Toscano, Vincenzo ^g   Arvat, Emanuela ^h   Bellastella, Antonio ^e   Mantero, Franco ^d   Falorni, Alberto ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; HLA ANTIGEN CLASS 2;

ADDISON DISEASE; ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CODOMINANCE; CONTROLLED STUDY; CTLA 4 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE ADENOMATOSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADDISON DISEASE; ALANINE; ANTIGENS, CD; AUTOIMMUNE DISEASES; GENETIC MARKERS; HUMANS; ITALY; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 75149154791     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0618     Document Type: Article

References (38)

1. Oelkers W. Adrenal insufficiency. New England Journal of Medicine 1996 335 1206-1212.
2. Nomura K, Depura H & Saruta T. Addison's disease in Japan: characteristics and changes revealed in a nationwide survey. Internal Medicine 1994 33 602-606.
3. Betterle C, Dal Pra C, Mantero F & Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Reviews 2002 23 327-364.
4. Winqvist O, Karlsson FA & Kämpe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992 339 1559-1562.
5. Bednarek J, Furmaniak J, Wedlock N, Kiso Y, Baumann-Antczak A, Fowler S, Krishnan H, Craft JA & Rees Smith B. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Letters 1992 309 51-55.
6. Falorni A, Nikoshkov A, Laureti S, Grenbäck E, Hulting AL, Casacci G, Santeusanio F, Brunetti P, Luthman H & Lernmark Å . High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. Journal of Clinical Endocrinology and Metabolism 1995 80 2752-2755.
7. Tanaka H, Perez MS, Powell M, Sanders JF, Sawicka J, Chen S, Prentice L, Asawa T, Betterle C, Volpato M, Rees Smith B & Furmaniak J. Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay. Journal of Clinical Endocrinology and Metabolism 1997 82 1440-1446.
8. Falorni A, Laureti S, Nikoshkov A, Picchio ML, Hallengren B, Vandewalle CL, Gorus FK, Belgian Diabetes Registry , Tortoioli C, Luthman H, Brunetti P & Santeusanio F. 21-Hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Clinical and Experimental Immunology 1997 107 341-345.
9. Robles DT, Fain PR & Eisenbarth GS. The genetics of autoimmune polyendocrine syndrome type II. Endocrinology and Metabolism Clinics of North America 2002 31 353-368.
10. Maclaren NK & Riley WJ. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome. Journal of Clinical Endocrinology and Metabolism 1986 62 455-459.
11. Gambelunghe G, Kockum I, Bini V, De Giorgi G, Celi F, Betterle C, Giordano R, Libè R & Falorni A. Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease. Diabetes 2005 54 900-905.
12. Myhre AG, Undlien DE, Løvå s K, Uhlving S, Nedrebø BG, Fougner KJ, Trovik T, Sørheim JI & Husebye ES. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. Journal of Clinical Endocrinology and Metabolism 2002 87 618-623.
13. Falorni A, Brozzetti A, La Torre D, Tortoioli C & Gambelunghe G. The association of genetic polymorphisms and autoimmune Addison's disease. Expert Review of Clinical Immunology 2008 4 441-456.
14. Laureti S, Vecchi L, Santeusanio F & Falorni A. Is the prevalence of Addison's disease underestimated? Journal of Clinical Endocrinology and Metabolism 1999 84 1762.
15. Løvå s K & Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clinical Endocrinology 2002 56 787-791.
16. Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, Candeloro P, Belladonna ML, Bianchi R, Fioretti MC & Puccetti P. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nature Immunology 2002 3 1097-1101.
17. Vaidya B & Pearce S. The emerging role of the CTLA-4 gene in autoimmune endocrinopathies. European Journal of Endocrinology 2004 150 619-626.
18. Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish PG, Usadel KH & Badenhoop K. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. Journal of Clinical Endocrinology and Metabolism 1997 82 4130-4132.
19. Kemp EH, Ajjan RA, Husebye ES, Peterson P, Uibo R, Imrie H, Pearce SH, Watson PF & Weetman AP. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. Clinical Endocrinology 1998 49 609-613.
20. Vaidya B, Imrie H, Geatch DR, Perros P, Ball SG, Baylis PH, Carr D, Hurel SJ, James RA, Kelly WF, Kemp EH, Young ET, Weetman AP, Kendall-Taylor P & Pearce SH. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. Journal of Clinical Endocrinology and Metabolism 2000 85 688-691.
21. Pérez de Nanclares G, Martín-Pagola A, Ramón Bilbao J, Vázquez F & Castaño L. No evidence of association of CTLA-4 polymorphisms with Addison's disease. Autoimmunity 2004 37 453-456.
22. Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES & Undlien DE. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. Journal of Clinical Endocrinology and Metabolism 2004 89 3474-3476.
23. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Rønningen KS, Guja C, Ionescu-Tîrgovişte C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA & Gough SC. Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 2003 423 506-511.
24. Ronningen KS, Keiding N, Green A & EURODIAB ACE Study Group. Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia 2001 44 B51-B59.
25. Falorni A, Laureti S, De Bellis A, Zanchetta R, Tiberti C, Arnaldi G, Bini V, Beck-Peccoz P, Bizzarro A, Dotta F, Mantero F, Bellastella A, Betterle C & Santeusanio F. Italian Addison Network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism 2004 89 1598-1604.
26. Gambelunghe G, Ghaderi M, Tortoioli C, Falorni A, Santeusanio F, Brunetti P, Sanjeevi CB & Falorni A. Two distinct MICA gene markers discriminate major autoimmune diabetes types. Journal of Clinical Endocrinology and Metabolism 2001 86 3754-3760.
27. Zetterquist H & Olerup O. Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Human Immunology 1992 34 64-74.
28. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MT, Teng WP, Park Y, Zhang ZX, Goldstein DR, Tao YW, Beaurain G, Bach JF, Huang HS, Luo DF, Zeidler A, Rotter JI, Yang MC, Modilevsky T, Maclaren NK & She JX. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphism in multiple ethnic groups. Human Molecular Genetics 1997 6 1275-1282.
29. Betterle C, Scalici C, Presotto F, Pedini B, Moro L, Rigon F & Mantero F. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. Journal of Endocrinology 1988 117 467-475.
30. Woolf B. On estimating the relation between blood group and disease. Annals of Human Genetics 1995 19 251-253.
31. Miettinen OS. The estimability and estimation in case-referent studies. American Journal of Epidemiology 1976 103 226-235.
32. Betterle C, Scalici C, Pedini B & Mantero F. Morbo di Addison: principali associazioni cliniche e descrizione della storia naturale della malattia. Annali Italiani di Medicina Interna 1989 4 195-206.
33. Gaunt TR, Rodriguez S, Zapata C & Day IN. MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers. BMC Bioinformatics 2006 27 227.
34. Begg CB & Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994 50 1088-1101.
35. Egger M, Smith GD, Schneider M& Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 315 629-634.
36. Tobias A. Assessing the influences of a single study in metaanalysis. Stata Technical Bulletin 1999 47 15-17.
37. Bax L, Yu LM, Ikeda N, Tsuruta H & Moons KGM. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Medical Research Methodology 2006 6 50.
38. Yu L, Brewer KW, Gates S, Wu A, Wang T, Babu SR, Gottlieb PA, Freed BM, Noble J, Erlich HA, Rewers MJ & Eisenbarth GS. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. Journal of Clinical Endocrinology and Metabolism 1999 84 328-335.